Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP-Reference-Cited by-同舟云学术

Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP

Published:2023-02-23 Issue:10 Volume:108 Page:2844-2849
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Bewarder Moritz,Kaddu-Mulindwa Dominic,Kos Igor Age,Lesan Vadim,Held Gerhard,Poeschel Viola,Thurner Lorenz,Bittenbring Joerg Thomas,Schmitz Norbert,Truemper Lorenz,Pfreundschuh Michael,Christofyllakis Konstantinos,Loeffler Markus,Altmann Bettina,Ziepert Marita

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference15 articles.

1. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006; 107(1):265-276.

2. Sant M, Allemani C, Tereanu C. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010; 116(19):3724-3734.

3. Fisher RI, Gaynor ER, Dahlberg S. Comparison of a standard regimen (CHOP) with 3hree intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med. 1993; 328(14):1002-1006.

4. Coiffier B, Lepage E, Brière J. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(4):235-242.

5. Pfreundschuh M, Trümper L, Österborg A. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-Bcell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006; 7(5):379-391.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma;Annals of Hematology;2024-09-04

2. Collision tumor of primary malignant lymphoma and adenocarcinoma in the colon, diagnosed by molecular genetics analyses: case report and review of literature;2023-05-18